Skip to main content
Top
Metadata
Title
Thalassemia and abnormal hemoglobin
Authors
Suthat Fucharoen
Pranee Winichagoon
Publication date
01-03-2002
Publisher
Springer-Verlag
Published in
International Journal of Hematology / Issue Special Issue 2/2002
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/BF03165094

Other articles of this Special Issue 2/2002

International Journal of Hematology 2/2002 Go to the issue

Update on Hypercoagulability

Treatment of venous thromboembolism

Current Concepts of the Myeloproliferative Diseases

What is the standard treatment in essential thrombocythemia

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine